Woyke M, Cwajda H, Wójcicki J
Pol J Pharmacol Pharm. 1978 Jan-Feb;30(1):77-81.
The effect of di-(1-isoquinolinyl)-di-(pyridyl-2')-butane (S-147) on platelet aggregation and adhesiveness as well as on blood lipids level (total lipids, triglycerides, total cholesterol) was tested in mongrel dogs, in comparison with carbocromen. The compounds administered iv (2 mg/kg/day) over 7 days inhibited ADP-induced aggregation, being without depressive influence on platelet adhesiveness. S-147 exhibited slightly stronger effect than carbocromen. The inhibition of platelet aggregation was accompanied by the decrease of serum lipids level.
在杂种犬中测试了二 -(1 - 异喹啉基)- 二 -(吡啶 - 2')- 丁烷(S - 147)对血小板聚集性和黏附性以及血脂水平(总脂质、甘油三酯、总胆固醇)的影响,并与卡波孟作比较。静脉注射给药(2毫克/千克/天),持续7天,这些化合物抑制了ADP诱导的聚集,对血小板黏附性无抑制作用。S - 147的作用略强于卡波孟。血小板聚集的抑制伴随着血脂水平的降低。